Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2136

1.

Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.

Zhai W, Li S, Zhang J, Chen Y, Ma J, Kong W, Gong D, Zheng J, Xue W, Xu Y.

Mol Cancer. 2018 Nov 12;17(1):157. doi: 10.1186/s12943-018-0906-x.

2.

Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer.

Root A, Beizaei A, Ebhardt HA.

Mol Cancer. 2018 Oct 31;17(1):156. doi: 10.1186/s12943-018-0905-y.

3.

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression.

Wu Q, Sun S, Li Z, Yang Q, Li B, Zhu S, Wang L, Wu J, Yuan J, Yang C, Li J, Sun S.

Mol Cancer. 2018 Oct 25;17(1):155. doi: 10.1186/s12943-018-0899-5.

4.

Therapeutic advances in anaplastic thyroid cancer: a current perspective.

Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS.

Mol Cancer. 2018 Oct 23;17(1):154. doi: 10.1186/s12943-018-0903-0. Review.

5.

Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.

Zhang K, Wang J, Yang L, Yuan YC, Tong TR, Wu J, Yun X, Bonner M, Pangeni R, Liu Z, Yuchi T, Kim JY, Raz DJ.

Mol Cancer. 2018 Oct 22;17(1):153. doi: 10.1186/s12943-018-0896-8.

6.

Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.

Lim MMK, Wee JWK, Soong JC, Chua D, Tan WR, Lizwan M, Li Y, Teo Z, Goh WWB, Zhu P, Tan NS.

Mol Cancer. 2018 Oct 20;17(1):152. doi: 10.1186/s12943-018-0904-z.

7.

Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis.

Liu H, Liu Y, Bian Z, Zhang J, Zhang R, Chen X, Huang Y, Wang Y, Zhu J.

Mol Cancer. 2018 Oct 18;17(1):151. doi: 10.1186/s12943-018-0902-1.

8.

Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations.

Choi H, Na KJ.

Mol Cancer. 2018 Oct 17;17(1):150. doi: 10.1186/s12943-018-0895-9.

9.

Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.

Schaal CM, Bora-Singhal N, Kumar DM, Chellappan SP.

Mol Cancer. 2018 Oct 15;17(1):149. doi: 10.1186/s12943-018-0901-2.

10.

Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.

Smeele P, d'Almeida SM, Meiller C, Chéné AL, Liddell C, Cellerin L, Montagne F, Deshayes S, Benziane S, Copin MC, Hofman P, Le Pimpec-Barthes F, Porte H, Scherpereel A, Grégoire M, Jean D, Blanquart C.

Mol Cancer. 2018 Oct 11;17(1):148. doi: 10.1186/s12943-018-0891-0.

11.

Effect of exosomal miRNA on cancer biology and clinical applications.

Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Yuan W.

Mol Cancer. 2018 Oct 11;17(1):147. doi: 10.1186/s12943-018-0897-7. Review.

12.

Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.

Zhang X, Shi H, Yuan X, Jiang P, Qian H, Xu W.

Mol Cancer. 2018 Oct 6;17(1):146. doi: 10.1186/s12943-018-0898-6.

13.

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells.

Cesi G, Philippidou D, Kozar I, Kim YJ, Bernardin F, Van Niel G, Wienecke-Baldacchino A, Felten P, Letellier E, Dengler S, Nashan D, Haan C, Kreis S.

Mol Cancer. 2018 Oct 5;17(1):145. doi: 10.1186/s12943-018-0886-x.

14.

Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.

Xie F, Li Y, Wang M, Huang C, Tao D, Zheng F, Zhang H, Zeng F, Xiao X, Jiang G.

Mol Cancer. 2018 Oct 3;17(1):144. doi: 10.1186/s12943-018-0892-z.

15.

Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.

Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, Lv Q, Qin C, Chu H, Wang M, Yuan L, Qian J, Zhang Z.

Mol Cancer. 2018 Oct 3;17(1):143. doi: 10.1186/s12943-018-0880-3.

16.

Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.

Zhan Y, Du L, Wang L, Jiang X, Zhang S, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Wang C.

Mol Cancer. 2018 Sep 29;17(1):142. doi: 10.1186/s12943-018-0893-y.

17.

The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.

Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B, Xu X, Xu T, Hu X, Sun L, He B, Pan Y, Sun H, Wang S.

Mol Cancer. 2018 Sep 28;17(1):141. doi: 10.1186/s12943-018-0894-x.

18.

Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.

Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT.

Mol Cancer. 2018 Sep 27;17(1):140. doi: 10.1186/s12943-018-0889-7.

19.

Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis.

Ma YS, Huang T, Zhong XM, Zhang HW, Cong XL, Xu H, Lu GX, Yu F, Xue SB, Lv ZW, Fu D.

Mol Cancer. 2018 Sep 21;17(1):139. doi: 10.1186/s12943-018-0890-1.

20.

Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer.

Tan S, Sun D, Pu W, Gou Q, Guo C, Gong Y, Li J, Wei YQ, Liu L, Zhao Y, Peng Y.

Mol Cancer. 2018 Sep 20;17(1):138. doi: 10.1186/s12943-018-0887-9.

Supplemental Content

Loading ...
Support Center